Cargando…
The compound heterozygous mutations of c.607G>a and c.657delC in the FAH gene are associated with renal damage with hereditary tyrosinemia type 1 (HT1)
BACKGROUND: Hereditary tyrosinemia type 1 (HT1) is a rare inherited metabolic disease characterized by severe liver and renal dysfunction. Early identification in affected children is critical for improved treatment options and prognosis. METHODS: In this study, we identified novel compound heterozy...
Autores principales: | Chi, Huan, Gan, Chun, Jiang, Yaru, Chen, Dan, Qiu, Jiawen, Yang, Qing, Chen, Yaxi, Wang, Mo, Yang, Haiping, Jiang, Wei, Li, Qiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834193/ https://www.ncbi.nlm.nih.gov/pubmed/36369907 http://dx.doi.org/10.1002/mgg3.2090 |
Ejemplares similares
-
Identification of Novel Mutations in FAH Gene and Prenatal Diagnosis of Tyrosinemia in Indian Family
por: Sheth, Jayesh J., et al.
Publicado: (2012) -
Clinical utility of nitisinone for the treatment of hereditary tyrosinemia type-1 (HT-1)
por: Das, Anibh Martin
Publicado: (2017) -
A case of megalencephalic leukoencephalopathy with subcortical cysts type 1 was identified with a novel compound heterozygous alteration (c.135delC; c.423+2dupT) in China
por: Dai, Cong‐Ling, et al.
Publicado: (2017) -
Syndrome of hereditary tyrosinemia in mink
por: Christensen, K, et al.
Publicado: (1978) -
The Somatic FAH c.1061C>A Change Counteracts the Frequent FAH c.1062+5G>A Mutation and Permits U1snRNA-Based Splicing Correction
por: Scalet, Daniela, et al.
Publicado: (2018)